Document Detail


Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
MedLine Citation:
PMID:  22309669     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Rotavirus vaccines have had a dramatic impact on morbidity and mortality from diarrhea among children in high- and middle-income countries that have introduced the vaccine into their national immunization programs. Widespread introduction of rotavirus vaccine in developing countries is imminent and their full potential in reducing the global burden from severe childhood diarrhea may soon be realized. The objectives of this paper are to describe the remaining issues and challenges in ensuring the success of the global rotavirus vaccination program and to discuss further research needed to help address them.
Authors:
Jacqueline E Tate; Manish M Patel; Margaret M Cortese; Benjamin A Lopman; Jon R Gentsch; Jessica Fleming; A Duncan Steele; Umesh D Parashar
Related Documents :
22303489 - Melioidosis vaccines: a systematic review and appraisal of the potential to exploit bio...
22693599 - Post-arrival health screening in karen refugees in australia.
22387629 - Protection of pigs against genital chlamydia trachomatis challenge by parenteral or muc...
22412979 - Us public support for vaccine donation to poorer countries in the 2009 h1n1 pandemic.
22732429 - Priming t-cell responses with recombinant measles vaccine vector in a heterologous prim...
22406459 - Vaccination of bovines against echinococcus granulosus (cystic echinococcosis).
11033729 - Prevention of childhood leukemia by bcg vaccination in newborns? a population-based cas...
16417949 - Mycobacterial 70 kd heat-shock protein is an effective subunit vaccine against bovine p...
6805409 - Bovine immunoglobulins and brucellosis. iv. study by microchromatographic technique of ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of vaccines     Volume:  11     ISSN:  1744-8395     ISO Abbreviation:  Expert Rev Vaccines     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101155475     Medline TA:  Expert Rev Vaccines     Country:  England    
Other Details:
Languages:  eng     Pagination:  211-20     Citation Subset:  IM    
Affiliation:
Centers for Disease Control and Prevention, 1600 Clifton Road, NE MS-A34, Atlanta, GA 30333, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Technologies for enhanced efficacy of DNA vaccines.
Next Document:  Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.